Results 131 to 140 of about 539,134 (347)

HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection. [PDF]

Transplant Cell Ther, 2023
Mehta RS, Cao K, Saliba RM, Al-Atrash G, Alousi AM, Lontos K, Marcoux C, Carmazzi Y, Rondon G, Bashir Q, Hosing CM, Kebriaei P, Khouri I, Marin D, Nieto Y, Oran B, Popat UR, Qazilbash MH, Ramdial J, Rezvani K, Champlin RE, Shpall EJ.   +21 more
europepmc   +1 more source

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

Molecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, Simon P. Gampenrieder, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Michael Hubalek, Katja Schmitz, Zsuzsanna Bago‐Horvath, Andreas Petzer, Sonja Heibl, Ellen Heitzer, Marija Balic, Michael Gnant   +14 more
wiley   +1 more source

HLA Linked Regional Differences in Donor Selection: A 9-Year Study of the Swiss Registry. [PDF]

Transfus Med Hemother, 2023
Kürsteiner O, Nicoloso G, Demont T, Büchler M, Tiercy JM.   +4 more
europepmc   +1 more source

Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus. [PDF]

, 1991
Kotaro Matsumoto, Y Yoshikai, T. Asano, Kunisuke Himeno, Akinori Iwasaki, K Nomoto   +5 more
openalex   +1 more source

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

Molecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Elin Borgen, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, Øystein Garred, Jon Lømo, Marius Stensland, Oddmund Nordgård, Ragnhild Sørum Falk, Randi R. Mathiesen, Hege G. Russnes, Jon Amund Kyte, Bjørn Naume   +13 more
wiley   +1 more source

Impacts of cigarette smoking on blood circulation: do we need a new approach to blood donor selection? [PDF]

J Health Popul Nutr, 2023
Wang J, Wang Y, Zhou W, Huang Y, Yang J.
europepmc   +1 more source

A METHOD OF SELECTION OF DONOR FOR BLOOD TRANSFUSION [PDF]

Journal of the American Medical Association, 1912
The possibility of iso-agglutination makes the choice of a donor for blood transfusion an important matter. It has been shown that individuals fall into definite groups as regards this phenomenon, and only a person belonging to the same group as the patient who is to be transfused should be selected as donor.
openaire   +3 more sources

How Far Shall We Go in the Predonation Selection of Blood Donors to Safeguard Patients for Blood-Transfusion-Related Infections? [PDF]

, 1993
H.W. Reesink, R.Y. Dodd, J. Leikola, P.V. Holland, G. Whyte, P. Hewitt, P. Kühnl, T. Dominka   +7 more
openalex   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini, Ezgi Oner, Mark P. Ward, Sinead Hurley, Brian David Henderson, Faye Lewis, Stephen P. Finn, Gerard J. Fitzmaurice, John J. O'Leary, Sharon O'Toole, Lorraine O'Driscoll, Kathy Gately   +11 more
wiley   +1 more source

Selecting Donor Recipients [PDF]

Biology of Blood and Marrow Transplantation, 2009
openaire   +3 more sources